Location History:
- Fox Chapel, PA (US) (1999)
- Pittsburgh, PA (US) (1999 - 2001)
- Monrovia, CA (US) (2013)
- Wynnewood, PA (US) (2022 - 2023)
Company Filing History:
2 out of 412 
1 out of 1,866 
3 out of 832,891 Years Active: 1999-2023
Title: **Arthur M. Feldman: A Pioneer in Heart Failure Therapeutics**
Introduction
Arthur M. Feldman, an accomplished inventor based in Wynnewood, PA, is renowned for his significant contributions to the field of medical science, particularly in the treatment of heart failure. With a remarkable portfolio of six patents, Feldman's innovative work focuses on novel therapeutic strategies aimed at improving patient outcomes.
Latest Patents
Feldman's most recent patents center on BCL2-associated athanogene 3 (BAG3) as a therapeutic target for heart failure. He developed compositions that include BAG3 molecules and agents capable of modulating the expression of these molecules, providing new avenues for pharmaceutical interventions. The patented compositions are designed for administration to patients suffering from heart failure, comprising one or more BAG3 molecules or modulating agents. Additionally, his patents outline methods for treatment and the identification of candidate therapeutic agents, reinforcing his impactful contributions to cardiovascular therapeutics.
Career Highlights
Arthur M. Feldman has had a distinguished career, significantly influenced by his roles in various reputable organizations. He has been associated with Temple University of the Commonwealth System of Higher Education, where he has furthered research and innovation in medical science. His work has not only garnered numerous patents but has also set the groundwork for future advancements in heart failure therapy.
Collaborations
Throughout his career, Feldman has collaborated with esteemed colleagues, including Douglas G. Tilley and Weizhong Zhu. These collaborations have fostered an environment of shared knowledge and innovation, contributing to the development of groundbreaking therapies and research in the medical field.
Conclusion
Arthur M. Feldman stands as a significant figure in the realm of therapeutic innovations for heart failure. His six patents reflect a deep commitment to improving patient care through scientific research and development. As the medical community continues to examine and apply his work, Feldman’s contributions will undoubtedly leave a lasting impact on the treatment and understanding of heart failure.